Condition: Cystic Fibrosis · Cystic Fibrosis-related Diabetes · Cystic Fibrosis With Intestinal Manifestations · Sponsor: Rhode Island Hospital
This study will evalute the effect of a low glycemic load (LGL diet on dysglycemia, insulin requirements, DXA-derived body composition, gastrointestinal symptoms and quality of life measures in adults with cystic fibrosis-related diabetes (CFRD). We will use continuous glucose monitors (CGM) to assess the LGL diet both in a controlled setting (via a meal delivery company) and in free-living conditions.
This description comes directly from the study's public registry record.
Kevin J Scully, MB BCh BAO · 401-444-5504 · kevin_scully@brown.edu
Melissa S Putman, MD, MSc · 617-355-7476 · melissa.putman@childrens.harvard.edu
Always discuss trial participation with your own doctor first.
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Rhode Island Hospital | Providence, Rhode Island, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05723445